The scientific community’s understanding of β-glucan induced trained immunity is still in its infancy; however, as Netea et al. hypothesize, the induction of trained immunity using β-glucan alone or in combination with immunotherapy will prove a novel and effective strategy for cancer treatment [93]. This evidence concerns the gene PPIB and cancer.